Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
More UBS Arbitration Claims Over Lehman Notes Likely Following Bankruptcy November 2, 2011 Staff Writers Add Your Comments Financial fraud lawyers are expecting an influx of arbitration claims against UBS Financial Services following an announcement that holders of Lehman Brothers principle protected notes (PPN) will only receive 21 cents for each dollar they invested out of the company’s bankruptcy. Late last week, the committee representing unsecured investors in the Lehman Brothers bankruptcy proceedings announced a reorganization plan, which will result in investors holding the company’s “guaranteed” notes realizing huge losses unless they take additional legal action, such as filing an arbitration claim against UBS with the Financial Industry Regulatory Authority (FINRA). The committee is expected to vote on Friday over whether to accept the bankruptcy plan or not. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Lehman Brothers faces claims of more than $320 billion from creditors who say the company owes them money. However, the company is likely to pay out only $65 billion of that. Creditors representing about $160 billion of that debt have already agreed to the company’s plans, which would lead what was once the fourth largest investment bank on Wall Street out of bankruptcy. Lehman notes were a hybrid financial instrument, constructed from a combination of stocks, bonds, currencies, commodities and derivatives, which were promoted by UBS and other brokers as low-risk investments, even as Lehman Brothers faced substantial financial troubles. Earlier this year, FINRA sanctioned UBS for misleading investors when selling them Lehman Brothers principal protected notes. FINRA ruled that UBS lead its investors to believe that the Lehman Brothers notes carried 100% principal protection. However, the notes were only protected to the extent Lehman Brothers was capable of paying. Lehman Brothers filed for bankruptcy in September 2008, causing the notes to become virtually worthless. FINRA accused UBS of omissions and statements that failed to emphasize that the Lehman notes were unsecured obligations of Lehman Brothers. FINRA officials said some of UBS’s mistakes came from trying to sell a product that was so complex even they did not understand it. A UBS class action lawsuit over Lehman structured notes was filed in 2008 in the U.S. District Court for the Southern District of New York, on behalf of all investors who were sold the investment by the brokerage firm. The complaint alleges that UBS brokers made false and misleading statements about Lehman Brothers Principal Protection Notes that omitted material facts about the risk associated with investing. Individual investors are also able to pursue damages against UBS through an arbitration claim with FINRA, which is a non-governmental regulatory body that handles resolution of disputes between investors and stockbrokers and other financial firms. It was created in July 2007, as a successor to the National Association of Securities Dealers, to arbitrate stock broker fraud claims that can include charges of breach of contract, breach of fiduciary duty, negligence, misrepresentation, unauthorized trading and other claims that investments were improperly handled. A number of arbitration claims and lawsuits over Lehman Brothers structured notes have already been filed on behalf of investors who were sold the products by UBS and other brokerage firms. Tags: Arbitration, Financial Advisor, Financial Fraud, FINRA, FINRA Arbitration, Lehman Brothers, Principal Protected Notes, UBS More Lawsuit Stories NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial May 29, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 Nicotine Pouch Use Leading to a New Generation of Addicts: Study May 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (Posted: today) Attorneys representing plaintiffs and defendants in infant formula NEC lawsuits will meet with a federal judge next month, as the litigation moves toward the next bellwether trial in August 2025. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITFDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)Childhood Antibiotic Use Could Lead to Increased Risks of Asthma, Allergies, Other Conditions: Study (04/28/2025) Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: yesterday) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025) Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: yesterday) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025)
NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial May 29, 2025
NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (Posted: today) Attorneys representing plaintiffs and defendants in infant formula NEC lawsuits will meet with a federal judge next month, as the litigation moves toward the next bellwether trial in August 2025. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITFDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)Childhood Antibiotic Use Could Lead to Increased Risks of Asthma, Allergies, Other Conditions: Study (04/28/2025)
Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: yesterday) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)
Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: yesterday) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025)